AMEETA KUMAR: Open Payments
NPI 1023705621 · FORT LAUDERDALE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$621 in 20 payments from 9 companies in 2025. Trend: 2023 $196 · 2024 $470 · 2025 $621
Food & beverage: $621
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $284 |
| CSL Behring | 3 | $80 |
| ARS Pharmaceuticals Operations, Inc. | 3 | $64 |
| GlaxoSmithKline, LLC. | 2 | $56 |
| Exact Sciences Corporation | 3 | $55 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $27 |
| Novo Nordisk Inc | 1 | $20 |
| Lilly USA, LLC | 1 | $18 |
| Dexcom, Inc. | 1 | $17 |
Products named: AIRSUPRA, NEFFY, Haegarda, NUCALA, Cologuard Collection Kit, JARDIANCE, Andembry, Ozempic.
Industry payments across FL — which companies pay providers there.
